A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer
Clinical trial NCT05908734 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05908734
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-18
- Primary completion
- 2027-01-31
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.